Key facts
- This page summarizes Danny L. Dearen's Form 4 filing for Axonics, Inc..
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Oct 2023, 19:37.
Danny L. Dearen - 29 Sep 2023 Form 4 Insider Report for Axonics, Inc.
- Reporting relationship
- President & CFO
- Issuer ticker
- N/A
- Reported as of
- 29 Sep 2023
- Net transaction value
- -$436,490
- SEC form
- 4
- Accepted by SEC
- 03 Oct 2023, 19:37:17 UTC
- Prior SEC filing
- 31 May 2023
- Next SEC filing
- 29 Jan 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Danny L. Dearen
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Danny L. Dearen filed Form 4 for Axonics, Inc. on 03 Oct 2023.
Change
- Previous filing in this sequence was filed on 31 May 2023.
- Current net transaction value: -$436,490.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AXNX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +11,250
- Change %
- +56%
- Price
- $0.000000
- Shares after
- 31,452
- Date
- 29 Sep 2023
- Ownership
- Direct
AXNX
transaction
Common Stock
Sale
- Transaction value
- $436,490
- Shares
- -7,675
- Change %
- -24%
- Price
- $56.87
- Shares after
- 23,777
- Date
- 29 Sep 2023
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AXNX
transaction
Derivative
Performance-Based Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -11,250
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 29 Sep 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 11,250
- Exercise price
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Danny L. Dearen is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 3 footnotes
Footnote F1
Shares of Issuer's common stock sold to cover the reporting person's tax obligation in connection with the conversion of the Performance-Based Restricted Stock Units disclosed herein.
Footnote F2
This transaction was executed in multiple trades at prices ranging from $56.51 to $57.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Footnote F3
Each Performance-Based Restricted Stock Unit represents the contingent right to receive one share of common stock, subject to the Issuer's achievement of certain operational and performance objectives during the fiscal year ending December 31, 2023. The units represented here are pro-rated through the date of separation.